Vicor's Q2 Boosted by Legal Windfall
Earnings Performance: Vicor reported a significant revenue increase of 64.3% year-over-year to $141 million, largely due to a one-time $45 million patent litigation settlement, with earnings per share reaching $0.91, far exceeding expectations.
Future Outlook and Challenges: Despite strong financial results, the company's backlog fell by 9.6%, indicating potential future order momentum issues, while management highlighted ongoing legal initiatives and tariff surcharges as factors to monitor moving forward.
Trade with 70% Backtested Accuracy
Analyst Views on VICR
About VICR
About the author
Vicor Corporation Schedules Q4 2025 Earnings Call on February 19, 2026
- Earnings Call Announcement: Vicor Corporation will hold its Q4 2025 earnings conference call on February 19, 2026, at 5:00 p.m. Eastern Time, where financial and operational results for the year ending December 31, 2025, will be discussed, followed by a Q&A session to enhance investor understanding of the company's performance.
- Financial Results Release: The fourth-quarter financial results will be released via GlobeNewswire at the close of the NASDAQ market, with a press release and summary of financial statements available shortly thereafter on Vicor's Investor Relations page, ensuring timely access to critical information for investors.
- Registration Requirements: Vicor encourages investors and analysts wishing to ask questions to register with Notified to receive dial-in information and a unique PIN, with registration closing at 5:00 p.m. on February 19, 2026, ensuring smooth participation in the call.
- Webcast and Replay Availability: For those unable to attend live, Vicor will provide a webcast and replay link on its Investor Relations page, ensuring all stakeholders can access the meeting content and enhancing information transparency.
Vicor VP Tuozzolo Sells 5,508 Shares for ~$498K Following Strong Earnings
- Transaction Overview: On October 24, 2025, Vicor's VP Claudio Tuozzolo exercised options and immediately sold 5,508 shares for approximately $498,863, indicating routine management of executive equity compensation.
- Ownership Change: This transaction reduced Tuozzolo's direct holdings by 14.08%, leaving him with 33,622 shares, which equates to 0.0747% of the company's outstanding shares, reflecting executive confidence in the company's outlook.
- Performance Drivers: Vicor reported third-quarter product and licensing revenues of $110.4 million, an 18.5% year-over-year increase, with net income soaring to $28.3 million, driving the stock price up 160% over the past year, significantly outperforming the S&P 500's 17% gain.
- Market Outlook: With management expecting IP settlements and licensing revenues to approach $300 million by 2026, Vicor's technological leadership in AI and electric vehicle power systems presents potential opportunities for growth investors.
Vicor VP Tuozzolo Sells 5,508 Shares for $498,862 Amid Strong Earnings
- Executive Transaction: On October 24, 2025, Vicor's Corporate VP Claudio Tuozzolo exercised and sold 5,508 shares of common stock for approximately $498,862, reflecting executive confidence in the company's stock.
- Holding Reduction: This transaction reduced Tuozzolo's direct holdings by 14.08%, from 39,130 to 33,622 shares, indicating a routine practice in equity management among executives.
- Strong Performance: Vicor reported third-quarter product and licensing revenues of $110.4 million, an 18.5% year-over-year increase, with net income soaring to $28.3 million, showcasing robust growth in high-density power technologies.
- Market Outlook: The company anticipates nearly $300 million in IP settlements and licenses by 2026, highlighting its technological leadership in AI and electric vehicle power systems, which may attract growth investors seeking exposure in these sectors.
Altimmune Inc Receives FDA Breakthrough Therapy Designation for Pemvidutide, Shares Surge 23.6%
- FDA Certification Impact: Altimmune Inc's Pemvidutide received FDA Breakthrough Therapy Designation, leading to a 23.6% surge in shares to $4.34 on Monday, indicating strong market confidence in its potential efficacy and possibly accelerating its path to market.
- Clinical Progress: GH Research PLC's GH001 lifted from FDA clinical hold saw shares rise 33.8% to $17.72, reflecting significant advancements in drug development that are expected to enhance its competitive position in the market.
- Executive Change: Rayonier Advanced Materials Inc appointed Scott M. Sutton as the new CEO, resulting in a 14.1% increase in shares to $6.68, suggesting that this leadership change could bring new strategic directions and growth opportunities for the company.
- Market Rebound: The overall market showed strong performance with the S&P 500 index rising, reflecting investor optimism about economic recovery, which may drive more capital inflows into the stock market.
Daily Upgrade Report for Validea Motley Fool Strategy - December 20, 2025
Validea's Small-Cap Growth Investor Model: Today's upgrades include Perma-Pipe International Holdings Inc (PPIH), which saw its rating increase from 69% to 76% based on strong fundamentals and valuation, indicating growing interest in the stock.
Company Overview - Perma-Pipe International Holdings Inc: The company specializes in pre-insulated piping and leak detection systems for various applications, operating in 14 locations across six countries.
Vicor Corp Rating Update: Vicor Corp (VICR), a mid-cap growth stock, had its rating rise from 65% to 72%, reflecting improved fundamentals and valuation, though it remains below the 80% threshold for strong interest.
Company Overview - Vicor Corp: Vicor designs and manufactures modular power components and systems, focusing on advanced power distribution architectures and offering a range of power conversion products.
Corporate Vice President Offloads $1.8 Million in Shares of AI Infrastructure Firm Vicor (Nasdaq: VICR)
Insider Stock Transactions: Claudio Tuozzolo, Corporate VP at Vicor, exercised 20,145 stock options and sold the shares, maintaining his direct ownership at 33,622 shares post-transaction, reflecting a liquidity event rather than a discretionary sale.
Vicor's Financial Performance: Vicor reported a significant Q3 performance with an 18.5% year-over-year revenue increase and per-share earnings of $0.63, far exceeding analyst expectations of $0.12, largely driven by demand for high-density power systems in AI data centers.
Market Reaction: Following the impressive earnings report, Vicor's stock surged over 55%, increasing its market cap from $2.2 billion to over $4 billion within a month, prompting other executives to exercise stock options as well.
Company Overview: Vicor specializes in advanced power conversion components and systems, catering to high-reliability markets such as aerospace and telecommunications, and generates revenue by supplying power solutions to OEMs and contract manufacturers globally.
Vicor Corporation Schedules Q4 2025 Earnings Call on February 19, 2026
- Earnings Call Announcement: Vicor Corporation will hold its Q4 2025 earnings conference call on February 19, 2026, at 5:00 p.m. Eastern Time, where financial and operational results for the year ending December 31, 2025, will be discussed, followed by a Q&A session to enhance investor understanding of the company's performance.
- Financial Results Release: The fourth-quarter financial results will be released via GlobeNewswire at the close of the NASDAQ market, with a press release and summary of financial statements available shortly thereafter on Vicor's Investor Relations page, ensuring timely access to critical information for investors.
- Registration Requirements: Vicor encourages investors and analysts wishing to ask questions to register with Notified to receive dial-in information and a unique PIN, with registration closing at 5:00 p.m. on February 19, 2026, ensuring smooth participation in the call.
- Webcast and Replay Availability: For those unable to attend live, Vicor will provide a webcast and replay link on its Investor Relations page, ensuring all stakeholders can access the meeting content and enhancing information transparency.
Vicor VP Tuozzolo Sells 5,508 Shares for ~$498K Following Strong Earnings
- Transaction Overview: On October 24, 2025, Vicor's VP Claudio Tuozzolo exercised options and immediately sold 5,508 shares for approximately $498,863, indicating routine management of executive equity compensation.
- Ownership Change: This transaction reduced Tuozzolo's direct holdings by 14.08%, leaving him with 33,622 shares, which equates to 0.0747% of the company's outstanding shares, reflecting executive confidence in the company's outlook.
- Performance Drivers: Vicor reported third-quarter product and licensing revenues of $110.4 million, an 18.5% year-over-year increase, with net income soaring to $28.3 million, driving the stock price up 160% over the past year, significantly outperforming the S&P 500's 17% gain.
- Market Outlook: With management expecting IP settlements and licensing revenues to approach $300 million by 2026, Vicor's technological leadership in AI and electric vehicle power systems presents potential opportunities for growth investors.
Vicor VP Tuozzolo Sells 5,508 Shares for $498,862 Amid Strong Earnings
- Executive Transaction: On October 24, 2025, Vicor's Corporate VP Claudio Tuozzolo exercised and sold 5,508 shares of common stock for approximately $498,862, reflecting executive confidence in the company's stock.
- Holding Reduction: This transaction reduced Tuozzolo's direct holdings by 14.08%, from 39,130 to 33,622 shares, indicating a routine practice in equity management among executives.
- Strong Performance: Vicor reported third-quarter product and licensing revenues of $110.4 million, an 18.5% year-over-year increase, with net income soaring to $28.3 million, showcasing robust growth in high-density power technologies.
- Market Outlook: The company anticipates nearly $300 million in IP settlements and licenses by 2026, highlighting its technological leadership in AI and electric vehicle power systems, which may attract growth investors seeking exposure in these sectors.
Altimmune Inc Receives FDA Breakthrough Therapy Designation for Pemvidutide, Shares Surge 23.6%
- FDA Certification Impact: Altimmune Inc's Pemvidutide received FDA Breakthrough Therapy Designation, leading to a 23.6% surge in shares to $4.34 on Monday, indicating strong market confidence in its potential efficacy and possibly accelerating its path to market.
- Clinical Progress: GH Research PLC's GH001 lifted from FDA clinical hold saw shares rise 33.8% to $17.72, reflecting significant advancements in drug development that are expected to enhance its competitive position in the market.
- Executive Change: Rayonier Advanced Materials Inc appointed Scott M. Sutton as the new CEO, resulting in a 14.1% increase in shares to $6.68, suggesting that this leadership change could bring new strategic directions and growth opportunities for the company.
- Market Rebound: The overall market showed strong performance with the S&P 500 index rising, reflecting investor optimism about economic recovery, which may drive more capital inflows into the stock market.
Daily Upgrade Report for Validea Motley Fool Strategy - December 20, 2025
Validea's Small-Cap Growth Investor Model: Today's upgrades include Perma-Pipe International Holdings Inc (PPIH), which saw its rating increase from 69% to 76% based on strong fundamentals and valuation, indicating growing interest in the stock.
Company Overview - Perma-Pipe International Holdings Inc: The company specializes in pre-insulated piping and leak detection systems for various applications, operating in 14 locations across six countries.
Vicor Corp Rating Update: Vicor Corp (VICR), a mid-cap growth stock, had its rating rise from 65% to 72%, reflecting improved fundamentals and valuation, though it remains below the 80% threshold for strong interest.
Company Overview - Vicor Corp: Vicor designs and manufactures modular power components and systems, focusing on advanced power distribution architectures and offering a range of power conversion products.
Corporate Vice President Offloads $1.8 Million in Shares of AI Infrastructure Firm Vicor (Nasdaq: VICR)
Insider Stock Transactions: Claudio Tuozzolo, Corporate VP at Vicor, exercised 20,145 stock options and sold the shares, maintaining his direct ownership at 33,622 shares post-transaction, reflecting a liquidity event rather than a discretionary sale.
Vicor's Financial Performance: Vicor reported a significant Q3 performance with an 18.5% year-over-year revenue increase and per-share earnings of $0.63, far exceeding analyst expectations of $0.12, largely driven by demand for high-density power systems in AI data centers.
Market Reaction: Following the impressive earnings report, Vicor's stock surged over 55%, increasing its market cap from $2.2 billion to over $4 billion within a month, prompting other executives to exercise stock options as well.
Company Overview: Vicor specializes in advanced power conversion components and systems, catering to high-reliability markets such as aerospace and telecommunications, and generates revenue by supplying power solutions to OEMs and contract manufacturers globally.
